Antibodies to SOCS Family - FocusOn 002
The eight members of the Suppressor of Cytokines Signaling (SOCS) family are SOCS-1-7, and CIS (cytokine inducible SH-2 domain protein). Structurally the SOCS proteins are composed of an N-terminal region of variable length and amino acid composition, a central SH2 domain, and a C-terminal motif called the SOCS box. The SOCS proteins appear to form part of a classical negative feedback loop that regulates cytokine signal transduction. Transcription of each of the SOCS genes occurs rapidly in vitro and in vivo in response to cytokines, and once produced, the various members of the SOCS family appear to inhibit signalling in different ways.
SOCS-1, also called JAK binding protein (JAB), is an SH2-domain containing protein. It interacts with all four Jak kinases (Jak1-3 and Tyk2) and inhibits the signaling action of IL-3, IL-4, IL-6, growth hormone, LIF, Prolactin, interferon gamma (IFN-g), and erythropoietin. It plays an important role in the negative regulation of IFN-? signaling and in the differentiation of T-cells. Biochemical characterization and gene disruption studies indicate that SOCS-1 is an important negative regulator of the JAK-STAT signal pathway.
SOCS-2, also known as CIS2, is capable of inhibiting cytokine signalling by interleukin-6 (IL-6) and growth hormone. SOCS-2 interacts with the phosphorylated insulin-like growth factor (IGF-I) receptor, where it may play a regulatory role in cellular growth, differentiation, and inhibition of apoptosis via the Ras and PI3K signalling pathways.
SOCS-3 is an important regulator of fetal liver haematopoiesis. It is also involved in a broad spectrum of cytokines, e.g. IL-2, IL-3, IL-4, IL-6, Epo, Prolactin, and GH.
SOCS-4 expression, in contrast to SOCS-1-3, does not appear to be EPO inducible. There also appear to be differential stabilities of the SOCS transcripts, SOCS-2 is the longest-lived and SOCS-1 and CIS the least stable. There is also evidence of EPO-independent expression of SOCS-3 and SOCS-4.
During Th1 differentiation a reduction in the association of Jak1 with the IL-4 receptor correlated with the appearance of SOCS-5. SOCS-5 protein was preferentially expressed in committed Th1 cells and interacted with the cytoplasmic region of the IL-4R alpha chain irrespective of receptor tyrosine phosphorylation. T cells from transgenic mice constitutively expressing SOCS-5 exhibited a significant reduction of IL-4-mediated Th2 development. Therefore, the induced SOCS-5 protein in Th1 differentiation environment may play an important role by regulating Th1 and Th2 balance.
SOCS-1 and SOCS-6 interact with the insulin receptor when expressed in human hepatoma cells. SOCS-1 and SOCS-6 inhibit insulin-dependent activation of ERK1/2 and protein kinase B in vivo and IR-directed phosphorylation of IRS-1 in vitro. These results suggest that SOCS proteins may be inhibitors of IR signalling and could mediate cytokine-induced insulin resistance.
Antibody tools for the Detection of SOCS Proteins
Acris Antibodies offers a collection of polyclonal and monoclonal antibodies to members of the SOCS family. These antibodies are useful for detection of SOCS1 – SOCS7 or CIS using Western blotting, immunoprecipitation or ELISA.
Fig.1: Cat.-No. AP15781PU-N SOCS3 antibody staining of Human Placenta.
Fig.2: Cat.-No. AP15780PU-N SOCS2 antibody staining of Human Pancreas.
Fig.3: Western blot analysis of SOCS1 using Cat.-No. SP7094 at 1:1000 dilution against 15 µg/lane of Ramos (A) and Raw (B) cell lysate.
Fig.4: Cat.-No. AP19007PU-N CIS antibody staining of HeLaS3 (A) whole cell lysate (30 µg) at 1/4000 dilution, 15% SDS PAGE.
Available Antibody Panel to SOCS
SOCS1, SOCS2, SOCS3, SOCS4, SOCS5, SOCS6, SOCS7, CIS antibody.
For specificity confirmation control peptides are available to use with SOCS-1, SOCS-2, SOCS-3, SOCS-4 and SOCS-5 antibody.
1 ml / €400.00
|Acris Antibodies GmbH|
0.1 ml / €170.00
|Acris Antibodies GmbH|
|Mouse||SO1||Purified||Hu||E, P, WB||
0.1 mg / €240.00
|IgG2b||Acris Antibodies GmbH|